Fas/FasL polymorphisms are associated with hepatitis C related cirrhosis and serum Alpha-Fetoprotein with hepatocellular carcinoma patients

Fas/FasL polymorphisms are associated with hepatitis C related cirrhosis and serum Alpha-Fetoprotein with hepatocellular carcinoma patients

Background: Host genetic factors that may confer a susceptibility to chronic hepatitis and the progression of hepatocellular carcinoma (HCC) are largely unknown. Apoptosis is an important fail-safe check for the hepatitis virus and HCC development, in which Fas/FasL hepatocyte expression contributes...

Full description

Bibliographic Details
Main Authors:	Guo-Shiou Liao, Ching-Hui Lo, Teng-Wei Chen, Jyh-Cherng Yu, Hung-Cheng Lai, Chung-Bao Hsieh, Tsan-Pai Liu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-03-01
Series:	Journal of Cancer Research and Practice
Subjects:	Fas Hepatocellular carcinoma Cirrhosis Genetic polymorphism
Online Access:	http://www.sciencedirect.com/science/article/pii/S2311300615000075

Similar Items

Leucemia mielóide crônica e o sistema Fas-FasL Chronic myeloid leukemia and the Fas-FasL system
by: Ana Paula F. Bergantini, et al.
Published: (2005-06-01)

Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis
by: A. Berdeli, et al.
Published: (2012-12-01)

Alteration of Regulation of Fas/FasL Mediated Apoptosis in Gastric Cancer
by: Reggie García Robles, et al.
Published: (2009-04-01)

The In Situ Hybridization Expression of Fas and Fas Ligand (FasL) in Trophoblastic tissue of Aborted Women Compared with Normal Pregnancy.
by: Amal H. Salman, et al.
Published: (2009-07-01)

Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation
by: Malgorzata Krzyzowska, et al.
Published: (2021-08-01)

Investigation of the Relation Between FAS, FASLG Polymorphisms and Serum Fas, FasL Levels in Patients with Psoriasis
by: Duran Gülay Gülbol, et al.
Published: (2018-07-01)

The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
by: Spasovski Vesna, et al.
Published: (2010-01-01)

Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer
by: Jolanta Czyżewska, et al.
Published: (2011-04-01)

Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling
by: Jiabin Yan, et al.
Published: (2015-03-01)

Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies
by: Josip Sremec, et al.
Published: (2020-11-01)

Expression of FasL in Proliferation of Retinoblastoma Cells: A Mechanism Fas Counterattack
by: Hendrian Dwikoloso Soebagjo, et al.
Published: (2014-08-01)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
by: Ikomey George M, et al.
Published: (2012-06-01)

FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders
by: Fusun Gediz Ozdemirkiran, et al.
Published: (2016-05-01)

Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
by: Giovanna Flores-Mendoza, et al.
Published: (2021-03-01)

Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis
by: Donghua Huang, et al.
Published: (2018-05-01)

Regulation of FasL expression and trafficking in cytotoxic T lymphocytes
by: He, Jinshu
Published: (2009)

Protective effect of trimetazidine on myocardial ischemia reperfusion injury in ovariectomized rats and the effect on Fas and FasL gene expression
by: Bo Zhao, et al.
Published: (2017-02-01)

Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese women
by: Wang M, et al.
Published: (2016-07-01)

Mild hypothermia reduces expression of Fas/FasL and MMP-3 after cerebral ischemia-reperfusion in rats
by: Jingkun Zhao, et al.
Published: (2014-06-01)

<i>Naja atra</i> Cardiotoxin 1 Induces the FasL/Fas Death Pathway in Human Leukemia Cells
by: Jing-Ting Chiou, et al.
Published: (2021-08-01)

Elevated Soluble Fas and FasL in Cerebrospinal Fluid and Serum of Patients With Anti-N-methyl-D-aspartate Receptor Encephalitis
by: Yue-Wen Ding, et al.
Published: (2018-10-01)

Modulation of Cell Death and Promotion of Chondrogenic Differentiation by Fas/FasL in Human Dental Pulp Stem Cells (hDPSCs)
by: Alessandra Pisciotta, et al.
Published: (2020-05-01)

FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma
by: El-Hamamsy M, et al.
Published: (2016-11-01)

FasL Modulates Expression of Mmp2 in Osteoblasts
by: Eva Svandova, et al.
Published: (2018-09-01)

Expression of Fas and Fas-L in renal cell carcinoma
by: Govedarović Vitomir, et al.
Published: (2006-01-01)

Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes
by: Adela Kratochvilova, et al.
Published: (2021-08-01)

NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL‐mediated extrinsic signaling pathway
by: Sanrong Xu, et al.
Published: (2018-09-01)

Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients
by: Agnès Hamzaoui, et al.
Published: (2003-01-01)

SFas and FasL in etiopathogenesis of autoimmune diseases of the thyroid gland and nodular forms of goiter
by: M. I. Sheremet, et al.
Published: (2015-12-01)

Enhanced Suppression of Immune Cells In Vitro by MSC Overexpressing FasL
by: Ana-Maria Vacaru, et al.
Published: (2021-12-01)

Hydrogen sulfide promotes immunomodulation of gingiva-derived mesenchymal stem cells via the Fas/FasL coupling pathway
by: Ruili Yang, et al.
Published: (2018-03-01)

Heat stress decreases egg production of laying hens by inducing apoptosis of follicular cells via activating the FasL/Fas and TNF-α systems
by: Gui-Ming Li, et al.
Published: (2020-11-01)

Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs)
by: Teresa Iwaniec, et al.
Published: (2012-01-01)

JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances tantitumor function in a Fas/FasL signal-independent pathway
by: Liu Y, et al.
Published: (2016-07-01)

Çocukluk çağı akut lenfoblastik lösemilerde serum Fas ve Fas Ligand düzeyleri
by: Alev ARSLAN, et al.
Published: (2019-12-01)

Combined Phosphatase and Tensin Homolog (PTEN) Loss and Fatty Acid Synthase (FAS) Overexpression Worsens the Prognosis of Chinese Patients with Hepatocellular Carcinoma
by: Xuehua Zhu, et al.
Published: (2012-08-01)

In vivo effects in melanoma of ROCK inhibition-induced FasL over-expression
by: Iotefa eTeiti, et al.
Published: (2015-07-01)

Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects
by: Yu XJ, et al.
Published: (2016-04-01)

Polymorphism of FAS and FAS ligand genes in alopecia areata: A case–control study in Egyptian population
by: Iman Seleit, et al.
Published: (2018-01-01)

Multipl Sklerozisli Hastalarda Serum sFas, sFas Ligand Düzeyleri ile FAS ve FASLG Polimorfizmleri Arasındaki İlişkinin Araştırılması
by: Gülay Gülbol Duran, et al.
Published: (2020-06-01)